CASCADIA: a prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults using a remote nasal swab collection and web-based survey design

INTRODUCTION: Although SARS-CoV-2 vaccines were first approved under Emergency Use Authorization by the Food and Drug Administration in late 2020 for adults, authorisation for young children 6 months to <5 years of age did not occur until 2022. These authorisations were based on clinical trials,...

Descripción completa

Detalles Bibliográficos
Autores principales: Babu, Tara M, Feldstein, Leora R, Saydah, Sharon, Acker, Zachary, Boisvert, Cassandra L, Briggs-Hagen, Melissa, Carone, Marco, Casto, Amanda, Cox, Sarah N, Ehmen, Brenna, Englund, Janet A, Fortmann, Stephen P, Frivold, Collrane J, Groom, Holly, Han, Peter D, Kuntz, Jennifer L, Lockwood, Tina, Midgley, Claire M, Mularski, Richard A, Ogilvie, Tara, Reich, Sacha L, Schmidt, Mark A, Smith, Ning, Starita, Lea, Stone, Jeremy, Vandermeer, Meredith, Weil, Ana A, Wolf, Caitlin R, Chu, Helen Y, Naleway, Allison L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350906/
https://www.ncbi.nlm.nih.gov/pubmed/37451722
http://dx.doi.org/10.1136/bmjopen-2022-071446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350906/
https://www.ncbi.nlm.nih.gov/pubmed/37451722
http://dx.doi.org/10.1136/bmjopen-2022-071446

Ejemplares similares